Ahn-Gook Pharmaceutical Statistics

Total Valuation

Ahn-Gook Pharmaceutical has a market cap or net worth of KRW 75.58 billion. The enterprise value is 124.15 billion.

Market Cap	75.58B
Enterprise Value	124.15B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Ahn-Gook Pharmaceutical has 11.37 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	11.37M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	55.60%
Owned by Institutions (%)	0.23%
Float	5.05M

Valuation Ratios

The trailing PE ratio is 4.92.

PE Ratio	4.92
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.45
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.58, with an EV/FCF ratio of -1.48.

EV / Earnings	8.09
EV / Sales	0.49
EV / EBITDA	9.58
EV / EBIT	16.91
EV / FCF	-1.48

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.47.

Current Ratio	1.76
Quick Ratio	1.21
Debt / Equity	0.47
Debt / EBITDA	7.06
Debt / FCF	-0.93
Interest Coverage	3.81

Financial Efficiency

Return on equity (ROE) is 9.33% and return on invested capital (ROIC) is 1.61%.

Return on Equity (ROE)	9.33%
Return on Assets (ROA)	1.27%
Return on Capital (ROIC)	1.61%
Revenue Per Employee	624.95M
Profits Per Employee	37.99M
Employee Count	404
Asset Turnover	0.95
Inventory Turnover	2.76

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.08%
50-Day Moving Average	7,133.60
200-Day Moving Average	7,676.50
Relative Strength Index (RSI)	27.07
Average Volume (20 Days)	18,423

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ahn-Gook Pharmaceutical had revenue of KRW 252.48 billion and earned 15.35 billion in profits. Earnings per share was 1,350.51.

Revenue	252.48B
Gross Profit	151.67B
Operating Income	5.40B
Pretax Income	21.74B
Net Income	15.35B
EBITDA	11.01B
EBIT	5.40B
Earnings Per Share (EPS)	1,350.51

Full Income Statement

Balance Sheet

The company has 28.63 billion in cash and 77.69 billion in debt, giving a net cash position of -49.06 billion or -4,316.47 per share.

Cash & Cash Equivalents	28.63B
Total Debt	77.69B
Net Cash	-49.06B
Net Cash Per Share	-4,316.47
Equity (Book Value)	166.11B
Book Value Per Share	14,658.58
Working Capital	59.45B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.24 billion and capital expenditures -73.59 billion, giving a free cash flow of -83.83 billion.

Operating Cash Flow	-10.24B
Capital Expenditures	-73.59B
Free Cash Flow	-83.83B
FCF Per Share	-7,375.87

Full Cash Flow Statement

Margins

Gross margin is 60.07%, with operating and profit margins of 2.14% and 6.08%.

Gross Margin	60.07%
Operating Margin	2.14%
Pretax Margin	8.61%
Profit Margin	6.08%
EBITDA Margin	4.36%
EBIT Margin	2.14%
FCF Margin	-33.20%

Dividends & Yields

This stock pays an annual dividend of 220.00, which amounts to a dividend yield of 3.31%.

Dividend Per Share	220.00
Dividend Yield	3.31%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	16.29%
Buyback Yield	-0.00%
Shareholder Yield	3.31%
Earnings Yield	20.31%
FCF Yield	-110.92%

Dividend Details

Stock Splits

The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.01.

Last Split Date	Dec 29, 2014
Split Type	Forward
Split Ratio	1.01

Scores

Ahn-Gook Pharmaceutical has an Altman Z-Score of 2.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	n/a